Selected Publications

Academic Article

Year Title Altmetric
2023 Making the Cut: Parathyroidectomy Before or After Kidney Transplantation?World Journal of Surgery.  47:319-329. 2023
2022 The risk and consequences of breakthrough SARS-CoV-2 infection in solid organ transplant recipients relative to non-immunosuppressed controlsAmerican Journal of Transplantation.  22:2418-2432. 2022
2022 COVID-19 Vaccination and Remdesivir are Associated With Protection From New or Increased Levels of Donor-Specific Antibodies Among Kidney Transplant Recipients Hospitalized With COVID-19Transplant International.  35. 2022
2022 Abnormal time-zero histology is predictive of kidney transplant outcomesClinical Transplantation.  36. 2022
2022 Factors associated with telemedicine utilization among post-transplant patients at a university kidney and pancreas transplant centerClinical Transplantation.  36. 2022
2022 Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the USJAMA Internal Medicine.  182:153-162. 2022
2022 Sex and organ-specific risk of major adverse renal or cardiac events in solid organ transplant recipients with COVID-19American Journal of Transplantation.  22:245-259. 2022
2021 COVID-19 in Solid Organ Transplantation: Results of the National COVID Cohort CollaborativeTransplantation Direct.  7. 2021
2021 Impact of Subclinical Borderline Inflammation on Kidney Transplant OutcomesTransplantation Direct.  7:E663. 2021
2020 Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes: A 15-year Single-center ExperienceAnnals of Surgery.  271:177-183. 2020
2019 Post-transplant lymphoproliferative disorder in a kidney transplant recipientClinical Journal of the American Society of Nephrology.  14:751-753. 2019
2018 Current opinions in organ allocationAmerican Journal of Transplantation.  18:2625-2634. 2018
2017 Quiz: Acute Kidney Injury and Pancytopenia 5 Months After Kidney TransplantationAmerican Journal of Kidney Diseases.  69:A14-A17. 2017
2016 Ergocalciferol treatment does Not improve erythropoietin utilization and hospitalization rate in hemodialysis patientsBMC Nephrology.  17:1-9. 2016
2016 Late Antibody-Mediated Rejection in Kidney Transplant Recipients: Outcomes after Intravenous Immunoglobulin TherapyClinical transplants.  32:111-118. 2016
2015 Comparison of Nutrition Profile and Diet Record Between Veteran and Nonveteran End-Stage Renal Disease Patients Receiving Hemodialysis in Veterans Affairs and Community Clinics in Metropolitan South-Central TexasNutrition in Clinical Practice.  30:698-708. 2015
2015 Treatment of vitamin D deficiency/insufficiency with ergocalciferol is associated with reduced vascular access dysfunction in chronic hemodialysis patientsHemodialysis International.  19:499-508. 2015
2014 Hydralazine induces myeloperoxidase and proteinase 3 anti-neutrophil cytoplasmic antibody vasculitis and leads to pulmonary renal syndrome.Case Reports in Nephrology.  2014:868590. 2014
2013 Chronic total occlusion and successful drug-eluting stent placement in Takayasu arteritis-induced renal artery stenosis 2013
2013 Increase in peritonitis rates with the reuse of drain tubing of the Fresenius liberty cyclerAdvances in peritoneal dialysis. Conference on Peritoneal Dialysis.  33:583-585. 2013
2013 A man with acute kidney injury and cutaneous purpuraAmerican Journal of Kidney Diseases.  62. 2013


Year Title Altmetric
2019 Azathioprine and mycophenolates.  212-230. 2019

Research Overview

  • Kidney Transplant
  • Investigator On

  • A Trial of Transplanting Hepatitis C-Viremic Kidneys Into Hepatitis C-Negative Kidney Recipients (THINKER-NEXT) Cost-Reimbursement  awarded by University of Pennsylvania
  • A Trial of Transplanting Hepatitis C-viremic Kidneys into Hepatitis C-Negative Kidney Recipients (THINKER-NEXT) Fixed Rate  awarded by University of Pennsylvania
  • APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • Applying Precision MEdicine to Optimize Desensitization with NoveL BIOlogics or Cellular TheRApies in Highly SensiTized Kidney Transplant PatiEnts (AMELIORATE)  awarded by THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients - Equipment  awarded by Mount Sinai School of Medicine ^
  • Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts  awarded by University of California, San Francisco
  • Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts  awarded by University of California, San Francisco
  • Private Grant  awarded by CAREDX INC.
  • Private Grant  awarded by QUARK PHARMACEUTICALS, INC.
  • Private Grant  awarded by MALLINCKRODT, INC.
  • Private Grant  awarded by ASTELLAS PHARMA US, INC.
  • Private Grant  awarded by TRANSPLANT GENOMICS, INC.
  • Private Grant  awarded by CSL BEHRING, LLC
  • Private Grant  awarded by VELOXIS PHARMACEUTICALS A/S
  • Private Grant  awarded by CSL BEHRING, LLC
  • Private Grant  awarded by TRANSPLANT GENOMICS, INC.
  • Private Grant  awarded by NATERA, INC.
  • Private Grant  awarded by CSL BEHRING, LLC
  • Private Grant  awarded by CAREDX INC.
  • Private Grant  awarded by TRANSPLANT GENOMICS, INC.
  • Using Microarrays to Assess Transplant Biopsies: The Future Standard of Care (INTERCOMEX: The INTERCOM Extension Study)  awarded by University of Alberta at Edmonton
  • Education And Training

  • University of Illinois Hospital, Residency
  • UAB SOM, Postdoctoral Fellowship
  • University of Texas Health Science Center, Postdoctoral Fellowship
  • Bachelor's Level Degree in Medicine, 2000
  • Full Name

  • Gaurav Agarwal